Calprotectin and Lactoferrin Faecal Levels in Patients with Clostridium difficile Infection (CDI): A Prospective Cohort Study

Weighted Versus Unweighted Charlson Score to Predict Long-term Other-cause Mortality in Men with Early-stage Prostate Cancer

(2014) Timothy J. Daskivich et al.   EUROPEAN UROLOGY

Clinical Utility of Fecal Biomarkers for the Diagnosis and Management of Inflammatory Bowel Disease

(2014) Uri Kopylov et al.   INFLAMMATORY BOWEL DISEASES

Is there any value in measuring faecal calprotectin in Clostridium difficile positive faecal samples?

(2014) S. J. Whitehead et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Markers of Intestinal Inflammation, Not Bacterial Burden, Correlate With Clinical Outcomes in Clostridium difficile Infection

(2013) Rana E. El Feghaly et al.   CLINICAL INFECTIOUS DISEASES

Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection

(2013) J. H. Boone et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection

(2013) Timothy D Planche et al.   LANCET INFECTIOUS DISEASES

Quantitative Fecal Lactoferrin in Toxin-Positive and Toxin-Negative Clostridium difficile Specimens: Table 1

(2012) P. Rocco LaSala et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comorbidity and competing risks for mortality in men with prostate cancer

(2011) Timothy J. Daskivich et al.   CANCER

The host immune response to Clostridium difficile

(2011) C. P. Kelly et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Patients' perspective of haemodialysis-associated symptoms

(2011) B. Caplin et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI

(2009) Alain M Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Ulcerative colitis

(2009) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea

(2009) D. R. van Langenberg et al.   INTERNAL MEDICINE JOURNAL

Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?

(2009) Valle García-Sánchez et al.   Journal of Crohns & Colitis

Toxin B is essential for virulence of Clostridium difficile

(2009) Dena Lyras et al.   NATURE

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings

(2008) T. SIPPONEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Prospective Multicenter Study Evaluating Fecal Calprotectin in Adult Acute Bacterial Diarrhea

(2008) Yogesh M. Shastri et al.   AMERICAN JOURNAL OF MEDICINE

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease

(2008) Jennifer Jones et al.   Clinical Gastroenterology and Hepatology

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease

(2008) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

(2007) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES